Sonnet BioTherapeutics Quote - SONN

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.5997

Bid

1.56

Offer

1.60

Volume

42,232

1.54 Day's Range 1.5999

1.41 52 Week Range 18.7192

Market Cap

4.904M

Previous Close

1.54

Open

1.55

Last Trade

1.5513

Last Trade Time

Financial Volume

US$ 66,354

VWAP

1.5712

Average Volume (3m)

1,119,987

Shares Outstanding

3,065,701

Dividend Yield

PE Ratio

-0.64

Earnings Per Share (EPS)

-2.43

Revenue

19k

Net Profit

-7.44M

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

Sector

Pharmaceutical Preparations

Industry

Management Consulting Svcs

Website

www.sonnetbio.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$1.54. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 1.41 to US$ 18.7192.

Sonnet BioTherapeutics currently has 3,065,701 shares in issue. The market capitalisation of Sonnet BioTherapeutics is US$4.72 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.64.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0003	-0.01875	1.6	1.6567	1.5	58436	1.57068859	CS
4	0.0497	3.2064516129	1.55	2.05	1.44	160479	1.78490092	CS
12	-1.3903	-46.4983277592	2.99	4.85	1.41	1119987	1.94715358	CS
26	-4.0403	-71.6365248227	5.64	10	1.41	758713	2.77541741	CS
52	-10.4803	-86.7574503311	12.08	18.7192	1.41	417609	3.73634862	CS
156	-729.4691	-99.7811833852	731.0688	1649.4016	1.41	1898154	551.43347385	CS
260	-15324.4803	-99.9895622364	15326.08	39916.8	1.41	2265961	2544.56514477	CS

SONN - Frequently Asked Questions (FAQ)

What is the current Sonnet BioTherapeutics share price?

The current share price of Sonnet BioTherapeutics is US$ 1.5997

How many Sonnet BioTherapeutics shares are in issue?

Sonnet BioTherapeutics has 3,065,701 shares in issue

What is the market cap of Sonnet BioTherapeutics?

The market capitalisation of Sonnet BioTherapeutics is USD 4.72M

What is the 1 year trading range for Sonnet BioTherapeutics share price?

Sonnet BioTherapeutics has traded in the range of US$ 1.41 to US$ 18.7192 during the past year

What is the PE ratio of Sonnet BioTherapeutics?

The price to earnings ratio of Sonnet BioTherapeutics is -0.64

What is the cash to sales ratio of Sonnet BioTherapeutics?

The cash to sales ratio of Sonnet BioTherapeutics is 250

What is the reporting currency for Sonnet BioTherapeutics?

Sonnet BioTherapeutics reports financial results in USD

What is the latest annual turnover for Sonnet BioTherapeutics?

The latest annual turnover of Sonnet BioTherapeutics is USD 19k

What is the latest annual profit for Sonnet BioTherapeutics?

The latest annual profit of Sonnet BioTherapeutics is USD -7.44M

What is the registered address of Sonnet BioTherapeutics?

The registered address for Sonnet BioTherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Sonnet BioTherapeutics website address?

The website address for Sonnet BioTherapeutics is www.sonnetbio.com

Which industry sector does Sonnet BioTherapeutics operate in?

Sonnet BioTherapeutics operates in the MANAGEMENT CONSULTING SVCS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	US$ 6.02 (133.33%)	104.48M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
WRDWeRide Inc	US$ 31.4877 (83.39%)	21.07M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.68M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	136.66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	489.28M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	417.31M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
INTCIntel Corporation	US$ 23.60 (-2.20%)	230.26M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	194.99M